Artificial intelligence dominated discussions on the opening day of WHX Labs at the Dubai World Trade Centre, as global experts explored how AI-powered diagnostics are accelerating the shift toward Healthcare 3.0. During the Laboratory Management track, thought leaders examined how advanced technologies are transforming laboratory medicine and clinical decision-making.
Dr Anmol Kapoor Highlights the Future of Healthcare 3.0
Leading the dialogue, Dr Anmol Kapoor, Founder, Chairman and CEO of BioAro, delivered a session titled “Bridging Multiomics to Clinical Realities: Harnessing AI for Delivering Healthcare 3.0.” He explained how advanced analytics, genomics, and artificial intelligence are redefining patient care and laboratory operations.
BioAro, which specialises in genomics, AI, and blockchain technologies, has developed an integrated platform that combines AI-driven genomic analysis, medical records, and interactive applications. As a result, the system generates comprehensive, end-to-end patient health profiles, enabling more precise and personalised interventions.
Understanding the Evolution from Healthcare 1.0 to 3.0
During his presentation, Dr Kapoor traced the evolution of healthcare models. He noted that Healthcare 1.0 relied on limited diagnostic tools, while Healthcare 2.0 introduced imaging technologies and digital health records. However, Healthcare 3.0 represents a more advanced and patient-centric phase.
This new model prioritises predictive, personalised, and digitally enabled care. By leveraging data analytics, AI, automation, and precision medicine, Healthcare 3.0 enables earlier disease detection, faster clinical decisions, and more targeted treatments.
“Healthcare 3.0 is more patient-centric and more personalised to you—to your DNA, your microbiome, and your epigenetics,” Dr Kapoor stated. “AI plays a critical role because it identifies patterns and interprets complex datasets, allowing clinicians to tailor care to each individual.”
Technology and Innovation Spotlight Sessions Continue
Dr Kapoor’s address formed part of the Technology and Innovation Spotlight sessions at WHX Labs. These sessions showcase cutting-edge advances in laboratory diagnostics and feature case studies that demonstrate the real-world clinical impact of emerging technologies.
Throughout the week, experts will explore additional topics, including novel neurodegenerative disease (NDD RUO) assays, implementation science in digitally enabled tuberculosis microscopy, and molecular diagnostics for infections affecting the skin, hair, and nails. Together, these sessions underline the expanding role of laboratories in shaping future healthcare systems.
Building Resilient Laboratories in Times of Crisis
Meanwhile, at the Laboratory Management Conference, Dr Talkmore Maruta, Director of Programs at the African Society of Laboratory Medicine, addressed the importance of emergency preparedness in healthcare organisations. In his session titled “Building Resilient Organisations Through Emergency Preparedness,” he reflected on lessons learned from the COVID-19 pandemic.
As per the press release, Dr Maruta emphasised that diagnostics remain central to effective outbreak response. “For any effective pandemic response, you must understand what is causing the outbreak,” he said. “Laboratories inform interventions and ensure health systems remain prepared.” He further highlighted that leadership often determines whether laboratories fail, survive, or successfully adapt during crises.
WHX Labs Marks 25 Years of Leadership in Diagnostics
Celebrating 25 years of excellence, WHX Labs continues to serve as the region’s leading laboratory and diagnostics event. Running from 10–13 February, the event takes place alongside WHX at the Dubai Exhibition Centre, collectively forming the world’s largest healthcare gathering.
The platform facilitates deal-making, networking, and knowledge exchange while addressing pressing challenges in laboratory science. Held under the patronage of the UAE Ministry of Health and Prevention, WHX Labs reinforces the nation’s commitment to advancing world-class healthcare and fostering resilient, future-ready health systems.